XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities    
Net income $ 4,187 $ 3,687
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 316 308
Noncash lease expense 108 123
Stock-based compensation 469 536
Deferred income tax expense (benefit) 41 (104)
Other investment gains 0 (276)
Net (gains) losses within CIPs (116) 510
Net (purchases) proceeds within CIPs (1,387) (804)
(Earnings) losses from equity method investees (304) 54
Distributions of earnings from equity method investees 32 27
Changes in operating assets and liabilities:    
Accounts receivable (607) 254
Investments, trading 52 217
Other assets (1,410) (2,273)
Accrued compensation and benefits (479) (1,282)
Accounts payable and accrued liabilities (67) 123
Other liabilities 1,332 1,883
Net cash provided by/(used in) operating activities 2,167 2,983 Close
Investing activities    
Purchases of investments (681) (516)
Proceeds from sales and maturities of investments 270 190
Distributions of capital from equity method investees 26 59
Net consolidations (deconsolidations) of sponsored investment funds 21 (48)
Acquisition, net of cash acquired (189) 0
Purchases of property and equipment (220) (399)
Net cash provided by/(used in) investing activities (773) (714) Close
Financing activities    
Repayments of long-term borrowings 0 (750)
Proceeds from long-term borrowings 1,238 0
Cash dividends paid (2,292) (2,259)
Proceeds from stock options exercised 51 0
Repurchases of common stock (1,500) (1,827)
Net proceeds from (repayments of) borrowings by CIPs (38) 0
Net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders 1,032 501
Other financing activities 20 19
Net cash provided by/(used in) financing activities (1,489) (4,316) Close
Effect of exchange rate changes on cash, cash equivalents and restricted cash (5) (479) Close
Net increase/(decrease) in cash, cash equivalents and restricted cash (100) (2,526) Close
Cash, cash equivalents and restricted cash, beginning of period 7,433 9,340
Cash, cash equivalents and restricted cash, end of period 7,333 6,814
Supplemental schedule of noncash investing and financing transactions:    
Issuance of common stock 554 567
Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (129) $ (514)